| | | | | |
AVTX Avalo Therapeutics, Inc. Common Stock | R$69,6331 | -1,79% | R$4,25B | R$7,10M | |
| R$235,77 | -3,11% | R$4,25B | R$656,03K | |
| R$102,09 | +1,41% | R$4,24B | R$1,28M | |
EVC Entravision Communication | R$42,4097 | -7,33% | R$4,24B | R$8,92M | |
ETON Eton Pharmaceutcials, Inc. Common Stock | R$140,31 | +0,82% | R$4,23B | R$1,48M | |
| R$131,22 | -3,80% | R$4,22B | R$667,56K | |
AMPH Amphastar Pharmaceuticals, Inc. | R$91,9807 | -1,84% | R$4,22B | R$1,95M | |
MATW Matthews International Corp | R$129,18 | -2,55% | R$4,20B | R$1,02M | |
TBPH Theravance Biopharma, Inc. | R$80,8069 | +2,12% | R$4,20B | R$1,34M | |
MPB Mid Penn Bancorp, Inc. | R$160,09 | -4,14% | R$4,20B | R$742,96K | |
KRO Kronos Worldwide, Inc. | R$35,1975 | -4,15% | R$4,20B | R$748,78K | |
ADAM Adamas Trust, Inc. Common Stock | R$44,5936 | -2,98% | R$4,19B | R$2,61M | |
CAPL CrossAmerica Partners LP Common units representing limited partner interests | R$111,18 | -0,23% | R$4,18B | R$108,88K | |
ROOT Root, Inc. Class A Common Stock | R$265,78 | -6,08% | R$4,18B | R$1,14M | |
EOI Eaton Vance Enhanced Equity Income Fund | R$100,51 | -0,75% | R$4,18B | R$290,78K | |
